Skip to content

Oligo-antigenic Diet in the Treatment of Chronic Anal Fissures.

Oligo-antigenic Diet in the Treatment of Chronic Anal Fissures. Evidence for a Relationship Between Food Hypersensitivity and Anal Fissures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01637857
Enrollment
161
Registered
2012-07-11
Start date
2006-01-31
Completion date
2010-12-31
Last updated
2013-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Fissures Treatment and Oligoantigenic Diet

Keywords

foof hypersensitivity, anal fissures, ano-rectal manometry

Brief summary

Patients with chronic constipation due to food hypersensitivity (FH) had an elevated anal sphincter resting pressure. No studies have investigated a possible role of FH in anal fissures (AF). We aim to evaluate the effectiveness of a diet in curing AF and the clinical effects of a double-blind placebo controlled (DBPC) challenge with cow's milk protein or wheat.

Detailed description

Context: Patients with chronic constipation due to food hypersensitivity (FH) had an elevated anal sphincter resting pressure. No studies have investigated a possible role of FH in anal fissures (AF). Objective: We aim to evaluate 1) the effectiveness of a diet in curing AF; 2) the clinical effects of a double-blind placebo controlled (DBPC) challenge with cow's milk protein or wheat. Design: The study will have two different parts: the first to verify the effectiveness of the oligo-antigenic diet in chronic AF treatment; the second to search for a possible cause-effect relationship between the diet and the onset of the AF. Setting: We will enrol consecutive adult patients with chronic AF who will refer to a Surgical Department of the University of Palermo for a 3-years period. Inclusion criteria are: evidence of CAF evaluated by an experienced rectal surgeon; patient age \>16 years. Exclusion criteria are: a diagnosis of inflammatory bowel disease, ongoing steroid treatment performed for any reason, an exclusion diet followed for any reason, and pregnancy. At the time of the first evaluation, routine laboratory tests, immunology tests, rectal biopsies and anal-rectal manometry will be performed. Patients: patients, finally included in the study, will be randomized to one of the treatment groups. Interventions: Enrolled patients will be randomized to receive a true elimination diet or a sham elimination diet; both groups will also receive topical nifedipine and lidocaine. Main Outcome Measures: The patients will be evaluated every two weeks for CAF persistence or healing; anal pain will be scored on a visual analogue scale ranging from 0 (absence of pain) to 10 (intolerable pain). Anal-rectal manometry will be repeated at the end of the study period, in all patients who will be treated.

Interventions

DIETARY_SUPPLEMENTsham oligoantigenic diet associated to lifestyle instruction

sham oligoantigenic diet associated to lifestyle instruction

DIETARY_SUPPLEMENToligoantigenic diet

oligoantigenic diet associated to life style counseling

Sponsors

University of Palermo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* evidence of chronic anal fissures evaluated by an experienced rectal surgeon * patient age \>16 years.

Exclusion criteria

* a diagnosis of inflammatory bowel disease * ongoing steroid treatment performed for any reason * an exclusion diet followed for any reason * pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Chronic anal fissures persistence or healing2 yearsThe patients will be evaluated every two weeks for eight weeks for CAF persistence or healing; anal pain will be scored on a visual analogue scale ranging from 0 (absence of pain) to 10 (intolerable pain). Anal-rectal manometry will be repeated at the end of the study period, in all patients who will be treated.

Secondary

MeasureTime frameDescription
Anal fissures recurring after Double-Blind Placebo-Controlled food challenge2 yearsIn this part of the study will be included patients with healed chronic anal fissures on true elimination diet (GROUP B) plus patients of GROUP A, who received sham elimination diet, uncured, were offered the treatment option of true elimination diet before undergoing surgery, accepted, and finally cured. Therefore, we will evaluate anal fissures recurring after Double-Blind Placebo-Controlled Food Challenges with cow's milk and wheat, and Open Challenges with other foods (i.e. egg, tomato and chocolate).

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026